508 related articles for article (PubMed ID: 10550166)
41. Summary and comparison of myeloid growth factor guidelines in patients receiving cancer chemotherapy.
Lyman GH; Kleiner JM
Cancer Treat Res; 2011; 157():145-65. PubMed ID: 21052955
[TBL] [Abstract][Full Text] [Related]
42. Impact of ASCO guidelines for the use of hematopoietic colony stimulating factors (CSFs): survey results of fifteen Paris university hospitals.
Debrix I; Madelaine I; Grenet N; Roux D; Bardin C; Le Mercier F; Fontan JE; Connor O; Pointereau A; Tilleul P
Pharm World Sci; 1999 Dec; 21(6):270-1. PubMed ID: 10658236
[TBL] [Abstract][Full Text] [Related]
43. Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel.
Gridelli C; Aapro MS; Barni S; Beretta GD; Colucci G; Daniele B; Del Mastro L; Di Maio M; De Petris L; Perrone F; Thatcher N; De Marinis F
Crit Rev Oncol Hematol; 2007 Jul; 63(1):53-64. PubMed ID: 17368037
[TBL] [Abstract][Full Text] [Related]
44. Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Quon H; Vapiwala N; Forastiere A; Kennedy EB; Adelstein DJ; Boykin H; Califano JA; Holsinger FC; Nussenbaum B; Rosenthal DI; Siu LL; Waldron JN
J Clin Oncol; 2017 Dec; 35(36):4078-4090. PubMed ID: 29064744
[TBL] [Abstract][Full Text] [Related]
45. Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Balaban EP; Mangu PB; Khorana AA; Shah MA; Mukherjee S; Crane CH; Javle MM; Eads JR; Allen P; Ko AH; Engebretson A; Herman JM; Strickler JH; Benson AB; Urba S; Yee NS
J Clin Oncol; 2016 Aug; 34(22):2654-68. PubMed ID: 27247216
[TBL] [Abstract][Full Text] [Related]
46. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
[TBL] [Abstract][Full Text] [Related]
47. ASCO Clinical Practice Guideline Endorsements and Adaptations.
Shah MA; Oliver TK; Peterson DE; Einhaus K; Schneider BJ; Denduluri N; Chavez-MacGregor M
J Clin Oncol; 2020 Mar; 38(8):834-840. PubMed ID: 31841361
[TBL] [Abstract][Full Text] [Related]
48. Clinical Outcomes and Cost-effectiveness of Primary Prophylaxis of Febrile Neutropenia During Adjuvant Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer.
Yu JL; Chan K; Kurin M; Pasetka M; Kiss A; Sridhar SS; Warner E
Breast J; 2015; 21(6):658-64. PubMed ID: 26387577
[TBL] [Abstract][Full Text] [Related]
49. Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement.
Resnick MJ; Lacchetti C; Bergman J; Hauke RJ; Hoffman KE; Kungel TM; Morgans AK; Penson DF
J Clin Oncol; 2015 Mar; 33(9):1078-85. PubMed ID: 25667275
[TBL] [Abstract][Full Text] [Related]
50. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
51. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
[TBL] [Abstract][Full Text] [Related]
52. A comparison of international guidelines for the prevention of chemotherapy-induced neutropenia.
Lyman GH
Curr Opin Hematol; 2011 Jan; 18(1):1-10. PubMed ID: 21042215
[TBL] [Abstract][Full Text] [Related]
53. Current attitudes and practice of American Society of Clinical Oncology-member clinical oncologists regarding cancer prevention and control.
Chlebowski RT; Sayre J; Frank-Stromborg M; Lillington LB
J Clin Oncol; 1992 Jan; 10(1):164-8. PubMed ID: 1727917
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United Kingdom.
Whyte S; Cooper KL; Stevenson MD; Madan J; Akehurst R
Value Health; 2011 Jun; 14(4):465-74. PubMed ID: 21669371
[TBL] [Abstract][Full Text] [Related]
55. Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline.
Rudin CM; Ismaila N; Hann CL; Malhotra N; Movsas B; Norris K; Pietanza MC; Ramalingam SS; Turrisi AT; Giaccone G
J Clin Oncol; 2015 Dec; 33(34):4106-11. PubMed ID: 26351333
[TBL] [Abstract][Full Text] [Related]
56. Canadian supportive care recommendations for the management of neutropenia in patients with cancer.
Kouroukis CT; Chia S; Verma S; Robson D; Desbiens C; Cripps C; Mikhael J
Curr Oncol; 2008 Jan; 15(1):9-23. PubMed ID: 18317581
[TBL] [Abstract][Full Text] [Related]
57. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
Brandon TH; Goniewicz ML; Hanna NH; Hatsukami DK; Herbst RS; Hobin JA; Ostroff JS; Shields PG; Toll BA; Tyne CA; Viswanath K; Warren GW
J Clin Oncol; 2015 Mar; 33(8):952-63. PubMed ID: 25572671
[TBL] [Abstract][Full Text] [Related]
58. Summary and comparison of myeloid growth factor guidelines in patients receiving cancer chemotherapy.
Lyman GH; Kleiner JM
J Natl Compr Canc Netw; 2007 Feb; 5(2):217-28. PubMed ID: 17335690
[TBL] [Abstract][Full Text] [Related]
59. [Assessment of Hungarian ESA and G-CSF treatments to national and international guidelines and protocols].
Nagy Z
Magy Onkol; 2013 Mar; 57(1):50-5. PubMed ID: 23573522
[TBL] [Abstract][Full Text] [Related]
60. Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project.
Wojtukiewicz M; Chmielowska E; Filipczyk-Cisarż E; Krzemieniecki K; Leśniewski-Kmak K; Litwiniuk MM; Wieruszewska-Kowalczyk K; Kosno-Kruszewska E
Contemp Oncol (Pozn); 2014; 18(6):425-8. PubMed ID: 25784842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
